176 related articles for article (PubMed ID: 36936373)
1. Identification and Validation of a m5C RNA Modification-Related Gene Signature for Predicting Prognosis and Immunotherapeutic Efficiency of Gastric Cancer.
Song L; Wang S; Li Q; Lu Y; Yang R; Feng X
J Oncol; 2023; 2023():9931419. PubMed ID: 36936373
[TBL] [Abstract][Full Text] [Related]
2. Development and Validation of a Novel Gene Signature for Predicting the Prognosis by Identifying m5C Modification Subtypes of Cervical Cancer.
Yu J; Liang LL; Liu J; Liu TT; Li J; Xiu L; Zeng J; Wang TT; Wang D; Liang LJ; Xie DW; Chen DX; An JS; Wu LY
Front Genet; 2021; 12():733715. PubMed ID: 34630524
[No Abstract] [Full Text] [Related]
3. Identification of a novel m5C/m6A-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma.
Ma Y; Yang J; Ji T; Wen F
Front Genet; 2022; 13():990623. PubMed ID: 36246622
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive Analysis of m5C Methylation Regulatory Genes and Tumor Microenvironment in Prostate Cancer.
Yu G; Bao J; Zhan M; Wang J; Li X; Gu X; Song S; Yang Q; Liu Y; Wang Z; Xu B
Front Immunol; 2022; 13():914577. PubMed ID: 35757739
[TBL] [Abstract][Full Text] [Related]
5. Contribution of m5C RNA Modification-Related Genes to Prognosis and Immunotherapy Prediction in Patients with Ovarian Cancer.
Liu Y; Liu S; Yan L; Zhang Q; Liu W; Huang X; Liu S
Mediators Inflamm; 2023; 2023():1400267. PubMed ID: 38022687
[TBL] [Abstract][Full Text] [Related]
6. Identification of M5c regulator-medicated methylation modification patterns for prognosis and immune microenvironment in glioma.
Xiao Z; Li J; Liang C; Liu Y; Zhang Y; Zhang Y; Liu Q; Yan X
Aging (Albany NY); 2023 Nov; 15(21):12275-12295. PubMed ID: 37934565
[TBL] [Abstract][Full Text] [Related]
7. RNA methylation-related genes of m6A, m5C, and m1A predict prognosis and immunotherapy response in cervical cancer.
Wang Y; Mao Y; Wang C; Jiang X; Tang Q; Wang L; Zhu J; Zhao M
Ann Med; 2023 Dec; 55(1):2190618. PubMed ID: 37042849
[TBL] [Abstract][Full Text] [Related]
8. 5-methylcytosine RNA methylation regulators affect prognosis and tumor microenvironment in lung adenocarcinoma.
Liu T; Hu X; Lin C; Shi X; He Y; Zhang J; Cai K
Ann Transl Med; 2022 Mar; 10(5):259. PubMed ID: 35402591
[TBL] [Abstract][Full Text] [Related]
9. Molecular Characterization and Clinical Characteristics of m5C-Based RNA Methylation in Spinal Cord Injury: Validated by qPCR.
Cao L; Pi WJ; Zhang Q; Li Q
Int J Genomics; 2022; 2022():5433860. PubMed ID: 36582430
[TBL] [Abstract][Full Text] [Related]
10. Modification of m5C regulators in sarcoma can guide different immune infiltrations as well as immunotherapy.
Wu S; Li M; Su R; Shen H; He Y; Zhou Y
Front Surg; 2022; 9():948371. PubMed ID: 36684288
[TBL] [Abstract][Full Text] [Related]
11. Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma.
Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Peng J; Xie Y
Front Cell Dev Biol; 2022; 10():971992. PubMed ID: 36081904
[No Abstract] [Full Text] [Related]
12. The RNA Methylation Modification 5-Methylcytosine Impacts Immunity Characteristics, Prognosis and Progression of Oral Squamous Cell Carcinoma by Bioinformatics Analysis.
Gao L; Chen R; Sugimoto M; Mizuta M; Zhou L; Kishimoto Y; Huang X; Omori K
Front Bioeng Biotechnol; 2021; 9():760724. PubMed ID: 34957065
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Significance and Tumor Immune Microenvironment Heterogenicity of m5C RNA Methylation Regulators in Triple-Negative Breast Cancer.
Huang Z; Pan J; Wang H; Du X; Xu Y; Wang Z; Chen D
Front Cell Dev Biol; 2021; 9():657547. PubMed ID: 33928086
[TBL] [Abstract][Full Text] [Related]
14. Overall Survival Signature of 5-Methylcytosine Regulators Related Long Non-Coding RNA in Hepatocellular Carcinoma.
Pan Q; Yi C; Zhang Y
Front Oncol; 2022; 12():884377. PubMed ID: 35686101
[TBL] [Abstract][Full Text] [Related]
15. Ovarian cancer subtypes based on the regulatory genes of RNA modifications: Novel prediction model of prognosis.
Zheng P; Li N; Zhan X
Front Endocrinol (Lausanne); 2022; 13():972341. PubMed ID: 36545327
[TBL] [Abstract][Full Text] [Related]
16. m5C regulator-mediated modification patterns and tumor microenvironment infiltration characterization in colorectal cancer: One step closer to precision medicine.
Chen B; Xi Y; Zhao J; Hong Y; Tian S; Zhai X; Chen Q; Ren X; Fan L; Xie X; Jiang C
Front Immunol; 2022; 13():1049435. PubMed ID: 36532062
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive Analysis of the Prognostic Value and Immune Infiltrates of the Three-m5C Signature in Colon Carcinoma.
Geng Q; Wei Q; Shen Z; Zheng Y; Wang L; Xue W; Li L; Zhao J
Cancer Manag Res; 2021; 13():7989-8002. PubMed ID: 34707405
[TBL] [Abstract][Full Text] [Related]
18. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
19. An m6A/m5C/m1A/m7G-Related Long Non-coding RNA Signature to Predict Prognosis and Immune Features of Glioma.
Shao D; Li Y; Wu J; Zhang B; Xie S; Zheng X; Jiang Z
Front Genet; 2022; 13():903117. PubMed ID: 35692827
[No Abstract] [Full Text] [Related]
20. Construction of a m5C-related long non-coding RNA signature for the prognosis of hepatocellular carcinoma.
Lu J; Wang H; Cao W; Chen D; He Z; Xu J
Hum Cell; 2023 Mar; 36(2):712-724. PubMed ID: 36520346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
